Article

Antitumor activity of a PPARdelta antagonist.

Vascular Biology Center, Division of Hematology Oncology and Transplantation, Department of Medicine, University of Minnesota Medical School, Minneapolis, MN 55455, USA.
Cancer biology & therapy (Impact Factor: 3.29). 08/2009; 8(13):1262-4. DOI: 10.4161/cbt.8.13.9061
Source: PubMed
0 Bookmarks
 · 
50 Views